Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DFJ DragonFund China, now primarily known as Draper Dragon, is a venture capital firm that specializes in early-stage and growth-stage investments in China and the United States. Established as a joint venture between Draper Fisher Jurvetson (DFJ) and DragonVenture, the firm focuses on high-growth sectors including information technology, media, and healthcare. In the life sciences sector, the firm targets investments in digital health, medical devices, and biotechnology companies that demonstrate cross-border potential. As a member of the Draper Venture Network, it provides its portfolio companies with access to a global ecosystem of resources and corporate partnerships. The firm maintains a strong presence in both Silicon Valley and Shanghai to facilitate technology transfer and market expansion between the two regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DFJ DragonFund China.